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Herpesviruses, which are major human pathogens,
establish life-long persistent infections. Although
the a, b, and g herpesviruses infect different tissues
and cause distinct diseases, they each encode a
conserved serine/threonine kinase that is critical for
virus replication and spread. The extent of substrate
conservation and the key common cell-signaling
pathways targeted by these kinases are unknown.
Using a human protein microarray high-throughput
approach, we identify shared substrates of the
conserved kinases fromherpes simplex virus, human
cytomegalovirus, Epstein-Barr virus (EBV), and
Kaposi’s sarcoma-associated herpesvirus. DNA
damage response (DDR) proteins were statistically
enriched, and the histone acetyltransferase TIP60,
an upstream regulator of the DDR pathway, was
required for efficient herpesvirus replication. During
EBV replication, TIP60 activation by the BGLF4
kinase triggers EBV-induced DDR and also mediates
induction of viral lytic gene expression. Identification
of key cellular targets of the conserved herpesvirus
kinases will facilitate the development of broadly
effective antiviral strategies.
INTRODUCTION
As major human pathogens, herpesviruses establish life-long
persistent infections that result in clinical manifestations ranging
from mild cold sores to pneumonitis, birth defects, and cancers.
Although the a, b, and g herpesviruses infect different tissues
and cause distinct diseases, they confront many of the same
challenges in infecting their hosts, reprogramming cell gene
expression, sensing and modifying cell-cycle state, and reacti-390 Cell Host & Microbe 10, 390–400, October 20, 2011 ª2011 Elsevvating the lytic life cycle to produce new virions and spread infec-
tion (Arvin et al., 2007). Whereas the a, b, and g mammalian
herpesviruses encode latency and transcriptional regulatory
genes that are unique to each subfamily, lytic cycle genes,
such as those encoding virion structural components and
proteins involved in replication of the viral genomes, are more
conserved across the order Herpesviridae. Among the con-
served gene products are the orthologous serine/threonine
protein kinases (UL13, UL97, BGLF4, and ORF36) encoded
by herpes simplex type 1 (HSV1), human cytomegalovirus
(HCMV), Epstein-Barr virus (EBV), and Kaposi’s sarcoma-asso-
ciated herpesvirus (KSHV), respectively (Gershburg and Pagano,
2008). These kinases are structurally similar to the cellular kinase
cdk2 (Romaker et al., 2006) and are recognized to phosphorylate
a number of cyclin-dependent kinase cellular targets, including
pRb (Hume et al., 2008), condensin (Lee et al., 2007), stathmin
(Chen et al., 2010), lamin A/C (Hamirally et al., 2009; Lee et al.,
2008; Meng et al., 2010), elongation factor 1 delta (Kato et al.,
2001; Kawaguchi and Kato, 2003; Kawaguchi et al., 2003),
MCM4 (Kudoh et al., 2006), and p27/KIP1 (Iwahori et al., 2009),
as well as viral targets, including KSHV bZIP (RAP) (Izumiya
et al., 2007), EBV EBNA1 and virion proteins (Zhu et al., 2009),
and HCMV UL69 (Rechter et al., 2009). Deletion of the protein
kinases or inhibition of their activity has been shown to impair
virus replication of HCMV and EBV in cultured cells (Gershburg
et al., 2007; Prichard et al., 1999; Wolf et al., 2001) and to reduce
the titer of HSV1 and murine g herpesvirus 68 (g-HV68) in in-
fected mice (Shibaki et al., 2001; Tarakanova et al., 2007).
Herpesvirus replication takes place against a background of
cell-cycle arrest overlaid with a pseudo S phase environment,
whereby virus replication becomes dissociated from cellular
DNA replication but selectively utilizes machinery normally acti-
vated during S phase (Kudoh et al., 2005; Li and Hayward, 2011).
The mimicry of cyclin-dependent kinase activity by the
conserved herpesvirus protein kinases contributes to the crea-
tion of the pseudo S phase replication environment. This
includes breakdown of the nuclear membrane, which is required
for egress of virus capsids from the nucleus and is dependent inier Inc.
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A/C (Hamirally et al., 2009; Lee et al., 2008; Meng et al., 2010).
Herpesvirus infection and lytic replication trigger the cellular
DNA damage response. The induced DNA damage response is
blunted during the establishment of latent herpesvirus infection,
in EBV by the latency protein EBNA3C (Nikitin et al., 2010), and in
HSV1 by the ICP0 protein (Lilley et al., 2010a). This attenuation of
the response is necessary for effective establishment of viral
latency. Conversely, aspects of the DNA damage pathway are
selectively incorporated into the herpesvirus lytic replication
program (Gaspar and Shenk, 2006; Kudoh et al., 2005; Lilley
et al., 2005; Shin et al., 2006) and are necessary for efficient viral
replication. In particular, early events such as activation of the
DNA damage response kinase, ataxia telangiectasia mutated
(ATM) protein, and phosphorylation of the ATM target H2AX
are detected in cells undergoing lytic herpesvirus replication.
The g-HV68 protein kinase (orf36) and the EBV protein kinase
BGLF4 have been shown to phosphorylate and activate ATM
and H2AX (Tarakanova et al., 2007).
The nucleoside analog drugs acyclovir and ganciclovir, which
are used to treat herpesvirus infections, require a monophos-
phorylation step that occurs in herpesvirus infected cells, but
not in uninfected cells, and conserved protein kinases can
mediate this phosphorylation (Gershburg et al., 2004; Meng
et al., 2010; Moore et al., 2001; Sullivan et al., 1992). The multiple
contributions of the conserved protein kinases to herpesvirus
replication and spread also make these kinases potential anti-
viral drug targets, although to date, only one inhibitor of protein
kinase enzymatic activity, maribavir, has entered clinical trials
(Prichard, 2009).
The herpesvirus protein kinases have a broader substrate
recognition than cellular cdks (Baek et al., 2002a; Cano-Monreal
et al., 2008; Romaker et al., 2006; Zhu et al., 2009) and neither
the full range of their substrates, nor the degree to which the
substrates of individual conserved protein kinases overlap, is
known. Comprehensive knowledge of common host targets
would provide valuable insight into key host factors that facilitate
herpesvirus replication and identify signaling pathways whose
targeting in combination could enhance the effectiveness of anti-
viral treatments. Using a human protein microarray screen, we
have identified more than 100 shared substrates of the a, b,
and g herpesvirus conserved kinases. Bioinformatic analyses
of these shared substrates revealed a statistical enrichment of
proteins involved in the DNA damage response. Follow-up
experimentation highlighted the key contribution to herpesvirus
replication of protein kinase-mediated-phosphorylation of the
histone acetlytransferase TIP60, a regulator of the DNA damage
response and of chromatin remodeling.
RESULTS
Common Host Substrate Identification for Conserved
Herpesvirus Protein Kinases
To identify common substrates for the herpesvirus-conserved
protein kinases, we performed assays on a human proteinmicro-
array composed of 4,191 unique human proteins, using the
UL13, UL97, BGLF4, and ORF36 orthologous kinases encoded
by the a, b, and g viruses HSV1, HCMV, and EBV and KSHV,
respectively (Figure 1A). Using normalized amounts of purifiedCell Hostviral kinases, as determined by autophosphorylation reactions,
we identified 273, 178, 290, and 294 substrates of BGLF4,
ORF36, UL97, and UL13, respectively, at a cutoff value of SD
R 3 (Figure 1A and Figure S1 and Table S1 available online).
Of the 643 nonredundant substrates collectively identified by
the four kinases, 110 are shared by at least three kinases (Fig-
ure 1B). Gene ontology (GO) analysis of these 110 common
substrates revealed involvement in eight major functional
classes, whereas statistical analysis indicated that the DDR
was significantly enriched (p = 0.004; hypergeometric test)
(Figures 1B and 1C). In addition, proteins in this DDR category
are also enriched for known association with viral infections
(p = 0.016; Table S2).
An effective means for a virus to exploit the host is to target
a master regulator that controls multiple downstream signaling
pathways. To identify such a master regulator, we applied
orthogonal analysis to the shared substrates by incorporating
different types of data (e.g., protein-protein and enzyme-
substrate interactions) and found a highly connected cluster of
12 proteins, all involved in the DDR (Figure 1C). Intriguingly,
several proteins are either the direct targets (e.g., CHK1,
RPA1, and RAD51) or downstream effectors of ATM kinase,
which plays a crucial role in DDR (Harper and Elledge, 2007).
ATM was not present on our protein microarrays. However,
recent studies have shown that the activation of ATM’s kinase
activity in response to DNA damage is dependent upon TIP60
(Sun et al., 2005), one of the substrates that was common to
the herpesvirus-conserved protein kinases (Figure 1C). Because
TIP60 plays an important role in both DDR and transcription
regulation through chromatin remodeling (Sapountzi et al.,
2006; Squatrito et al., 2006), it is a candidate master regulator
of the herpesvirus life cycle. Therefore, we focused on TIP60
and its role in herpesvirus replication.
EBV BGLF4 Regulates Lytic Replication through
the Phosphorylation and Activation of TIP60
Choosing EBV as the primary model, we first tested whether
TIP60 expression affected viral DNA replication. Both Akata
(EBV+) B cells and SNU719 (EBV+) gastric carcinoma cells
were transformed with individual shRNA lentiviral constructs to
knock down TIP60 expression. As a surrogate for viral DNA repli-
cation, wemeasured the EBV genome copy following lytic induc-
tion of EBV by IgG crosslinking and bortezomib treatment,
respectively. Knockdown of TIP60 was incomplete (Figure S2)
but, nonetheless, reduced the number of EBV genomes by
60%–80% on both cell backgrounds and with both lytic induc-
tion treatments (Figure 2A). Measurement of extracellular infec-
tious virus found an 90% reduction upon TIP60 silencing (Fig-
ure 2B). Because the observed decrease was shown with two
different shRNAs, the phenotype is unlikely to be due to off-
target shRNA effects. These results indicate that TIP60 is a phys-
iologically relevant substrate in the EBV life cycle.
To demonstrate that TIP60 is a target of the EBV kinase BGLF4
in cells, we first showed that TIP60 interacted with both a wild-
type (WT) BGLF4 and a kinase-dead mutant (BGLF4KD) in trans-
fected cells using reciprocal coimmunoprecipitations (co-IPs)
(Figures 3A and S3A). Note that, though the loss of BGLF4 kinase
activity did not affect its interaction with TIP60, there was a
change in TIP60 mobility with BGLF4KD, indicating that BGLF4& Microbe 10, 390–400, October 20, 2011 ª2011 Elsevier Inc. 391
Figure 1. Identification of CommonHost Protein Substrates fora, b, and gHumanHerpesvirus Protein Kinases: Enrichment of Proteins in the
DNA Damage Pathway
(A) Autoradiograph showing representative sections of typical protein array phosphorylation assays performed using the four viral kinases. All substrates are
printed in duplicate. The rectangle highlights a common substrate, Pumilio2.
(B) Venn diagram illustrating the overlap in substrate specificity of the herpesvirus protein kinases. Of 643 total substrates, the highlighted 110 host proteins were
phosphorylated by at least three kinases. See also Table S1 and Figure S1.
(C) Interaction network for the 110 shared host proteins. Proteins are color coded by their functional classes. An asterisk indicates the enriched functional class of
19 proteins involved in DDR. Proteins in the inner oval (light yellow) are nuclear proteins. whereas the proteins in the outer ring are in other cellular compartments.
Edges between the proteins represent known or predicted connections, such as protein-protein interactions, catalytic reactions, and enzyme-substrate rela-
tionships, obtained from the database STRING (http://string-db.org/). Note that ATM was not present on the human protein array. See also Tables S1 and S2.
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Herpesvirus Kinases Activate TIP60plays a role in TIP60 phosphorylation. BGLF4-TIP60 interaction
during EBV infection was validated using EBV-positive Akata
(EBV+) cells induced into the lytic cycle by treatment with IgG
to cross-link the B cell receptor and antibodies against endoge-
nously expressed TIP60 (Figure 3B). Autologous EBV-negative
Akata 4E3 cells (EBV) served as a negative control. Having
shown that BGLF4 directly phosphorylated TIP60 in vitro (Fig-
ure S3B), we sought to determine which sites on TIP60 were
phosphorylated. In a previous study, phosphorylation at Ser86
and Ser90 of TIP60 was shown to enhance its HAT activity
in vitro using histones as substrates. In addition, GSK3b and
CDK1/cyclin B were found to in vitro phosphorylate Ser86 and
Ser90, respectively (Charvet et al., 2011; Lemercier et al.,
2003). Because BGLF4 and CDK1/cyclin B have overlapping
substrate recognition (Hume et al., 2008; Zhu et al., 2009), we
created TIP60 constructs carrying single or double mutations
at Ser86 and Ser90. To show that BGLF4 directly phosphorylates
TIP60 at Ser86, an in vitro phosphorylation assay was per-392 Cell Host & Microbe 10, 390–400, October 20, 2011 ª2011 Elsevformed. We found that the TIP60 pSer86-specific antibody de-
tected phosphorylation of WT TIP60, but not phosphorylation
of the S86A or S86/90A mutants (Figure 3C). Further, immuno-
blot analysis of TIP60 coprecipitated from WT TIP60-, S86A-,
or S86/90A-transfected cell extracts by anti-BGLF4 antibody re-
vealed that the S86A and S90A mutations each affected TIP60
mobility, with the effects of the double mutation being additive
(Figure 3D). Phosphatase treatment increased the mobility of
WT TIP60 coprecipitated with WT BGLF4 to equal that of WT
TIP60 coprecipitated with BGLF4KD and also equal to that of
the S86/90A double mutant. This indicates that TIP60 Ser86/90
are major sites of phosphorylation by BGLF4. To further confirm
Ser86 phosphorylation of TIP60 in vivo, we monitored Ser86
phosphorylation of endogenous TIP60 upon induction of WT
BGLF4 or BGLF4KD and found that Ser86 phosphorylation was
dependent on the presence of BGLF4 kinase activity (Figure 3E,
left). These results were further supported in lytically induced
Akata (EBV+) cells, in which Ser86 phosphorylation of TIP60ier Inc.
Figure 2. TIP60 Is Required for Efficient EBV Lytic Replication
(A) TIP60 silencing impairs lytic DNA replication. Relative viral genome copy
numbers measured by qPCR in lytically induced Akata (EBV+) and SNU719
(EBV+) cells carrying control shRNA (GFP-sh) or TIP60 shRNAs (TIP60-sh1,
TIP60-sh2). The experiments were performed in triplicate with ± SD shown.
*p < 0.02, **p < 0.01. See also Figure S2A.
(B) TIP60 silencing reduces infectious virus production. Relative EBV titer
produced by lytically induced Akata BX1(EBV+) cells carrying control shRNA
(GFP-sh) or TIP60 shRNAs (TIP60-sh1, TIP60-sh2) was measured using Raji
cell infection assay. The experiments were carried out in triplicate with ± SD
shown. **p < 0.01. See also Figure S2B.
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ure 3E, right).
To investigate whether the histone acetyltransferase (HAT)
activity of TIP60 is affected by BGLF4 phosphorylation, we
compared HAT activity of WT and S86/90A TIP60 coexpressed
with either WT BGLF4 or BGLF4KD. TIP60 was immunoprecipi-
tated, and its HAT activity was measured in vitro (Figures 3F
and S3C). TIP60s HAT activity in the presence of WT BGLF4
was 3-fold greater than that seen with BGLF4KD, indicating that
BGLF4’s phosphorylation of TIP60 substantially enhances its
HATactivity. This result was further supported by the observation
that the S86/90A double mutation reduced TIP60’s HAT activity
to that of a HAT-deficient TIP60 mutant, regardless of the pres-
ence or absence of WT BGLF4 or BGLF4KD (Figures 3F and
S3C). Taken together, the data establish that BGLF4 interacts
with and phosphorylates TIP60 to increase TIP60’s HAT activity.BGLF4 Induces the DNA Damage Response
and Chromatin Remodeling through TIP60
TIP60 mediates chromatin remodeling, and TIP60 acetylation of
ATM activates ATM autophosphorylation and ATM transphos-
phorylation of downstream targets such as those illustrated in
Figure 4A. Although DDR and chromatin remodeling have been
implicated in herpesvirus replication, the molecular mechanisms
are poorly understood (Lilley et al., 2010b). Therefore, we exam-
ined whether BGLF4 regulates DDR and chromatin remodeling
via TIP60. As shown in Figure 4B, the presence of a series of
DNA damage markers, including pSer1981 of ATM, pThr68 of
CHK2, and pSer139 of histone H2AX (g-H2AX), is dependent
on induction of WT BGLF4, but not BGLF4KD, in Akata (EBV+)
cells, and inhibition of ATM abolishes these effects. In addition,
Lys5 acetylation of histone H2A (H2AK5Ac), a known target of
TIP60, is substantially enhanced upon BGLF4 induction regard-
less of ATM inhibition (Figure 4B, lanes 5 and 8). Moreover, in
a time course of lytic induction in Akata (EBV+) cells, BGLF4
appearance coincides with TIP60 phosphorylation, ATM activa-Cell Hosttion, and g-H2AX generation (Figure S4A). Consistent with this
result, when endogenous BGLF4 is knocked down after lytic
induction, ATM Ser1981 autophosphorylation is reduced to the
same level as that seen in TIP60 knockdown cells, suggesting
that BGLF4-induced DDR depends on TIP60. Moreover, in the
same context, the phosphorylation of ATM’s downstream effec-
tors, CHK2 (pThr68) and H2AX (pSer139 or g-H2AX), and the
acetylation of TIP60s direct target, H2AK5Ac, are also BGLF4
dependent (Figure 4B, right).
To test whether BGFL4-/TIP60-dependent activation of DDR
via ATM plays a role in EBV lytic replication, we measured extra-
cellular virus produced by Akata BX1 (EBV+) cells in the latent
state (0 hr) or after lytic induction (48 and 96 hr) in the absence
or presence of an ATM inhibitor. We found that EBV lytic replica-
tion was suppressed in a dose-dependent manner by ATM inhi-
bition (Figures 4C and S4B), demonstrating the critical role of
ATM in EBV lytic replication.
A recent study showed that inhibition of DDR kinases ATM and
Chk2markedly increases the efficiency of EBV latency establish-
ment in B cells (Nikitin et al., 2010). Because TIP60 acts
upstream of ATM and CHK2, we asked whether inhibition of
TIP60 also increases EBV latency establishment. Using the
GFP-tagged virus produced by Akata BX1 cells and a Raji B
cell infection assay, we found that latency establishment was
increased in Raji cells carrying TIP60 shRNA compared to cells
carrying control shRNA (Figures 4D and S4C).
BGLF4 Induces the Expression of Key Lytic Viral Genes
through TIP60
To further illustrate the integration of BGLF4 and DDR into EBV
DNA replication, we demonstrated that BGLF4 was recruited
to the EBV lytic replication origin (OriLyt) upon lytic induction
and that its presence induced the recruitment of g-H2AX and
the accumulation of H2AK5Ac at the same locus (Figure 4E).
Because TIP60 is known to acetylate histones and regulate
gene expression (Avvakumov and Coˆte´, 2007; Baek et al.,
2002b; Ikura et al., 2000), we reasoned that the accumulation
of H2AK5Ac at this promoter induced by TIP60 could also
contribute to viral gene expression. Therefore, we investigated
whether the OriLyt (BHLF1) promoter or other promoters are tar-
geted by TIP60 during lytic induction.
We performed chromatin immunoprecipitation (ChIP) assays
coupled with real-time PCR to quantitatively survey 18-well-
annotated EBV promoter regions, including the OriLyt (BHLF1)
promoter, for TIP60 occupancy. The selected promoters are
distributed across the EBV genome (de Jesus et al., 2003) and
control 22 EBV genes (Figure 5A). Using antibody against endog-
enous TIP60 in lytically induced Akata (EBV+) cells, we found that
TIP60 associated with the BHLF1 (OriLyt) and RTA promoters
and also with both promoters (ED-L1 and L1-TR) that regulate
LMP1 (Figure 5A), whereas no significant enrichment of TIP60
was observed on the other tested promoters. These results indi-
cate that TIP60 associates with specific EBV promoters. We next
examined the dynamics of this relationship to compare TIP60
occupancy of the BHLF1 (OriLyt), RTA, and LMP1 promoters
during latency and postlytic induction. TIP60 association was
not detected during latent infection of Akata (EBV+) cells, but
TIP60 was recruited to all three promoters at 12 hr postinduction
and remained associated at 24 hr (Figure 5B, top). In contrast, the& Microbe 10, 390–400, October 20, 2011 ª2011 Elsevier Inc. 393
Figure 3. BGLF4 Interacts with, Phosphory-
lates, and Activates TIP60
(A) Both EBV BGLF4 and kinase-dead BGLF4
interact with TIP60. Western blot analysis of
transfected 293T cell extracts showing copreci-
pitation of TIP60 with BGLF4. BGLF4KD, BGLF4
kinase-dead mutant. Input, 2% whole-cell lysate
used for IP. See also Figure S3A.
(B) Interaction between endogenous TIP60 and
EBV BGLF4. Lytically induced Akata (EBV+) and
Akata 4E3 (EBV) cell extracts were immunopre-
cipitated with control IgG or anti-TIP60 antibodies,
and the precipitated proteins were immunoblotted
with the indicated antibodies. Input, 1%whole-cell
lysate used for IP.
(C) BGLF4 phosphorylates TIP60 at S86 in vitro.
Western blot analysis after in vitro phosphorylation
reactions with indicated combinations of BGLF4
and wild-type or mutant TIP60.
(D) TIP60 Ser86 (S86) and Ser90 (S90) are
substrates for BGLF4. Immunoblot comparing the
mobility of BGLF4- and kinase-dead BGLF4-
coprecipitated wild-type and mutant FLAG-TIP60
with and without phosphatase treatment. 293T
cells were transfected as indicated and then
treated with 20 mM roscovitine for 12 hr before
harvest. See also Figure S3B.
(E) BGLF4 induces TIP60 S86 phosphorylation
in vivo. Western blot analysis of cell extracts from
Akata (EBV+) cells carrying empty vector, BGLF4,
or BGLF4KD, with or without doxycycline (DOX,
20 ng/ml) treatment, and cell extracts from lytically
induced Akata (EBV+) cells carrying control GFP,
BGLF4, or TIP60 shRNAs.
(F) BGLF4 increases TIP60 HAT activity. Relative
HAT activity of wild-type TIP60 (WT), phosphory-
lation-deficient TIP60 (S86/90A), and HAT-dead
TIP60 (HD) immunoprecipitated from 293T cells
transfected with wild-type BGLF4 (WT) or
BGLF4KD (KD) constructs. The experiments were
carried out in triplicate with ± SD shown. *p < 0.01.
Immunoprecipitated TIP60 loading controls are
shown in Figure S3C.
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course of lytic induction. To determine BGLF4’s role in this
process, we used shRNA lentiviral constructs to knock down
BGLF4 expression in Akata (EBV+) B cells and then examined
TIP60’s recruitment to the BHLF1, RTA, and LMP1 promoters
during the course of EBV lytic induction (Figure 5B, middle).
Quantitative measurement by qPCR showed that TIP60’s occu-
pancy on the three promoters was reduced by at least 50%
between 12 and 24 hr postinduction (Figure S5A). Thus, BGLF4
enhances TIP60’s recruitment to these three viral promoters.
Importantly, the three EBV genes targeted by TIP60 play key
roles in viral replication. RTA is one of two key transcriptional
activators that drive early and late lytic EBV gene expression (Za-
lani et al., 1996). The BHLF1 (OriLyt) promoter is an essential
component of the viral lytic origin of replication (Schepers
et al., 1993). LMP1 is a latency gene, but its expression is upre-
gulated in the lytic cycle, where LMP1 provides key functions for
cell survival and virus release (Ahsan et al., 2005; Dirmeier et al.,
2005; Uchida et al., 1999). To correlate TIP60 recruitment and
BGLF4 function with the efficiency of expression of these EBV394 Cell Host & Microbe 10, 390–400, October 20, 2011 ª2011 Elsevgenes, we generated Akata (EBV+) cells that expressed BGLF4
shRNA (BGLF4-sh), TIP60 shRNA (TIP60-sh), or control GFP
shRNA (GFP-sh). In the control GFP-sh Akata cells, as expected,
these three genes and BMRF1were highly upregulated at 12 and
24 hr postinduction (Figure 5B, bottom). However, in BGLF4-sh
and TIP60-sh cells (Figures 5B, bottom, and S5B), the expres-
sion level of BHLF1, RTA, and LMP1 was significantly reduced
at both time points, whereas BMRF1 expression was minimally
affected. TIP60 expression was not altered by BGLF4-sh (Fig-
ure S5C). Interestingly, TIP60 knockdown had a greater negative
impact thanBGLF4 knock down (Figure 5B, bottom). To summa-
rize, the results reveal that EBV exploits TIP60 via BGLF4 phos-
phorylation to drive lytic viral gene expression. RTA-induced
transcription of BGLF4 leads to reinforced RTA transcription
and, consequently, to enhanced expression of the RTA-regu-
lated lytic viral replication program (Wang et al., 2010).
Conserved Role for TIP60 in Herpesvirus Replication
Finally, we tested whether the interplay between the viral kinases
and TIP60 is conserved in the other herpesviruses. Using theier Inc.
Figure 4. BGLF4 Induces the DNA Damage Response through TIP60
(A) Schematic illustration of BGLF4’s potential function in DDR and chromatin remodeling through TIP60 phosphorylation. P, phosphorylation; Ac, acetylation.
(B) BGLF4 induces histone acetylation and ATM activation via TIP60 phosphorylation. Western blot analysis of cell extracts from Akata (EBV+) cells carrying
empty vector, BGLF4, or BGLF4KD, with or without doxycycline (DOX, 20 ng/ml) or ATM inhibitor (KU55933, 15 mM) treatment, as indicated, and cell extracts from
lytically induced Akata (EBV+) cells carrying control GFP, BGLF4, or TIP60 shRNAs. See also Figure S4A. The data are representative of at least two independent
biological replicates.
(C) ATM inhibitor inhibits EBV lytic replication. Relative EBV titer of lytically induced Akata BX1(EBV+) cells in the absence or presence of ATM inhibitor (KU55933),
as indicated, was measured using Raji cell infection assay. The experiments were carried out in triplicate with ± SD shown. *p < 0.01. See also Figure S4B.
(D) TIP60 knockdown increases the efficiency of EBV latency establishment. EBV BX1 virus was used to infect Raji cells carrying control scramble shRNA (Scram-
sh) or TIP60 shRNA (TIP60-sh1). Phorbol-12-myristate-13-acetate (TPA) (20 ng/ml) and sodiumbutyrate (3mM)were added 6 days postinfection, and the number
of the GFP-positive Raji cells was calculated to determine the efficiency of latency establishment. *p < 0.01. See also Figure S4C.
(E) Lytic induction results in the recruitment of BGLF4 and g-H2AX to the EBV lytic replication origin (OriLyt) promoter and enrichment of histone acetylation (H2A
Lys5 acetylation, H2AK5Ac) on this promoter. ChIP-PCR analysis performed on Akata (EBV+) cells carrying indicated shRNAs showing BGLF4, g-H2AX, and
H2AK5Ac enrichment at the OriLyt promoter after lytic induction.
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Herpesvirus Kinases Activate TIP60same approaches described above, we showed that KSHV
ORF36, HCMV UL97, and, to a lesser extent, HSV1 UL13 phos-
phorylated and increased the mobility of TIP60 in cotransfected
HeLa cells (Figure 6A) and interacted with TIP60 in transfected
293T cells (Figures 6B, 6C, S6A, and S6B). In addition, we tested
for recruitment of TIP60 at the HCMV lytic replication origin
(OriLyt) and found that, similar to EBV, TIP60 was recruited to
HCMV oriLyt at 24, 48, and 96 hr postinfection (hpi) (Figure 6D).
Furthermore, knockdown of TIP60 in HCMV-infected cells signif-
icantly reduced production of extracellular HCMV virion DNA
(Figures 6E and S6C). HCMV lytic replication was also signifi-
cantly suppressed by an ATM inhibitor in a dose-dependent
manner (Figures 6F and S6D), suggesting that the mechanism
of inhibition parallels that shown for EBV. These results demon-
strate that the viral kinase-TIP60 partnership is conserved and
represents a common virus-host interaction.Cell HostDISCUSSION
High-throughput technology is emerging as a powerful tool for
the discovery of factors involved in pathogen-host interactions
(Brass et al., 2009; Calderwood et al., 2007; Karlas et al.,
2010; Ko¨nig et al., 2010; Shapira et al., 2009). Here, we took
a protein microarray approach to identify enzyme-substrate
interactions for four conserved human herpesvirus kinases,
with the hypothesis that the common substrates would reveal
host pathways that are critical for replication across the herpes-
virus family. By analyzing more than 100 shared host substrates,
we identified the DDR pathway as a central target of the
conserved herpesvirus kinases. Mechanistic studies showed
that, in the absence of external DNA damage cues, the EBV
kinase phosphorylated and activated the histone acetyltransfer-
ase TIP60, an upstream master regulator of DDR. In addition,& Microbe 10, 390–400, October 20, 2011 ª2011 Elsevier Inc. 395
Figure 5. Regulation of EBV Lytic Gene
Expression through TIP60
(A) TIP60 recruitment to EBV promoters. The EBV
genome annotated with the 18 tested promoters
(triangles) and origins of DNA replication (dots).
(Red bars) Relative TIP60 occupancy normalized
to the IgG control.
(B) Impact of TIP60 recruitment and BGLF4
activity on EBV lytic gene expression. (Top) ChIP-
PCR analysis performed on Akata (EBV+) cells
showing TIP60 enrichment at the BHLF1, RTA,
and LMP1 (L1-TR) promoters after lytic induction,
but not the BMRF1 lytic promoter. (Middle)
Recruitment of TIP60 to the BHLF1, RTA, and
LMP1 (L1-TR) promoters was reduced in BGLF4-
sh Akata (EBV+) cells. (Bottom) RT-qPCR analysis
of mRNA levels for the corresponding genes and
a nonenriched gene (BMRF1) in Akata (EBV+) cells
carrying the indicated shRNAs. The experiments
were carried out in triplicate with ± SD shown. See
also Figure S5.
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Herpesvirus Kinases Activate TIP60TIP60 was integrated into the virus lytic program by recruitment
to the viral chromatin, where TIP60 activated specific EBV genes
critical for viral replication.
TIP60 was originally identified as a partner of the HIV type 1
(HIV-1) transactivator, Tat (Kamine et al., 1996), and is targeted
by several viruses. Human T cell lymphotropic virus type 1
(HTLV-1) p30II enhances Myc transforming activity through
stabilizing Myc-TIP60 transcriptional interactions (Awasthi
et al., 2005). TIP60 interaction with viral TAT, E6, and UL27
proteins encoded by HIV-1, human papillomavirus (HPV), and
HCMV, respectively, induces TIP60 degradation (Col et al.,
2005; Jha et al., 2010; Reitsma et al., 2011), which is believed
to enable establishment of viral latency and enhance virus-
induced oncogenesis. In the case of HCMV, viruses deleted or
mutated for the UL97 protein kinase escape through secondary
mutations in the UL27 protein that degrades TIP60 (Chou,
2009; Reitsma et al., 2011). A recent study by Nikitin et al. found
that theDDR induced uponEBV infection is a robust host antiviral
defense, and EBV employs countermeasures to overcome the
growth inhibitory effects of the host DDR in order to establish
latency (Nikitin et al., 2010). These authors found that treatment
of B cells with an ATM inhibitor increased latency establishment.396 Cell Host & Microbe 10, 390–400, October 20, 2011 ª2011 Elsevier Inc.We find here that TIP60 inhibition with
shRNA also increases latency establish-
ment, implying that TIP60 is an upstream
mediator ofDDR induceduponEBV infec-
tion. Interestingly, BGLF4 is present in the
EBV tegument (Asai et al., 2006) and,
consequently, is introduced into cells
upon EBV infection. Therefore, BGLF4
would be available to initiate a transient
activation of TIP60, and the DDR and
BGLF4/TIP60 partnership may be an
important factor in inducing a cellular
environment that is hostile to latency
establishment.
In counterpoint, we demonstrate that
TIP60 plays a positive role in the lyticreplication of herpesviruses: TIP60 shRNA significantly reduces
virus production from b and g herpesvirus-infected cells. In the
case of EBV, TIP60 HAT activity is enhanced via phosphoryla-
tion by the EBV-encoded protein kinase BGLF4 at the same
sites that are phosphorylated by CDC2/CDK1 and GSK3b
(Charvet et al., 2011; Lemercier et al., 2003). This interaction
is sufficient to trigger DDR. DDR plays an important role in the
lytic viral life cycle. EBV lytic replication elicits DDR by triggering
ATM autophosphorylation and activation. Activated ATM
phosphorylates its downstream targets, such as H2AX, p53,
CHK2, and RPA2, and phosphorylated ATM, RPA2, and
Mre11/Rad50/Nbs1 (MRN) complexes are recruited to replica-
tion compartments in nuclei during EBV lytic replication (Kudoh
et al., 2005; Kudoh et al., 2009). However, the mechanism
of virus-triggered ATM activation has been elusive. Although
g-HV68 kinase orf36 and EBV BGLF4 have been found to
directly phosphorylate H2AX, this phosphorylation was reduced
significantly in ATM-deficient cells (Tarakanova et al., 2007) and
also, as shown here in Figure 4B, in cells treated with an ATM
inhibitor. As summarized in Figure 7, our experiments mecha-
nistically link the viral kinases to ATM and its downstream
targets CHK2 and H2AX via TIP60.
Figure 6. Conserved Role for TIP60 in
Herpesvirus Replication
(A) Western blot analysis showing that KSHV
ORF36 and HCMV UL97 increase the mobility of
TIP60 in transfected HeLa cells.
(B and C) TIP60 coprecipitates with (B) KSHV
ORF36, (C) HCMV UL97, and HSV1 UL13 using
contransfected 293T cells. Reciprocal immuno-
precipitations are presented in Figures S6A and
S6B. Input, 2% whole-cell lysate used for IP.
(D) TIP60 is recruited to HCMV lytic replication
origin (OriLyt) at 24, 48, and 96 hr postinfection
(hpi).
(E) TIP60 is required for efficient HCMV replication.
Relative supernatant virion DNA from HCMV-in-
fected HF cells (96 hpi) carrying control scramble
shRNA (Scram-sh) or TIP60 shRNA (TIP60-sh) was
determined with qPCR. The experiments were
carried out in triplicate with ± SD shown. *p < 0.01.
See also Figure S6C.
(F) ATM inhibitor inhibits HCMV replication. Rela-
tive supernatant virion DNA from HCMV-infected
HF cells (96 hpi) in the absence or presence of
ATM inhibitor (KU55933) was determined with
qPCR. The experiments were carried out in tripli-
cate with ± SD shown. *p < 0.01, **p < 0.005. See
also Figure S6D.
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Herpesvirus Kinases Activate TIP60We also demonstrate that TIP60 plays a positive role in tran-
scriptional regulation of key lytic viral genes (Figure 7). BGLF4
has been implicated in facilitating viral egress from the nucleus
by phosphorylating lamins (Lee et al., 2008). Interestingly, we
find that TIP60 is recruited to the LMP1 promoters after lytic
induction and is needed for achieving normal levels of lytic
LMP1 transcription. LMP1 downstream signaling is important
for nuclear egress of virions (Ahsan et al., 2005), and our data
suggest that TIP60-mediated activation of LMP1 expression
represents another mechanism by which BGLF4 promotes
this aspect of infectious EBV production. TIP60’s negative
role in the establishment of latency and its positive role in lytic
viral replication place TIP60 at the decision point between viral
latency establishment and productive lytic replication (Figures 2
and 4D).
This work illustrates the value of high-throughput, unbiased
approaches for the discovery of conserved viral targets. There
are few drugs available to treat herpesvirus infections, and viral
escape mutants develop upon extensive use of this limited
repertoire. The herpesvirus protein kinases are attractive antiviral
drug targets. However, developing broadly effectively drugs
requires knowledge of their common cellular substrates. The
information provided by our common substrate identificationCell Host & Microbe 10, 390–400,will assist in the design of assays for
new and broadly effective antiherpesvi-
rus therapeutics.
EXPERIMENTAL PROCEDURES
Kinase Assay
Phosphorylation of proteins on human protein
arrays by herpesvirus protein kinases was as-
sayed as previously described (Ptacek et al.,2005; Zhu et al., 2009). The list of the 4,191 unique proteins on this array
can be found in Table S2 of Hu et al. (Hu et al., 2009). Detailed information is
described in the Supplemental Experimental Procedures.
Immunoprecipitation and ChIP Assays
Cells were transfected using Lipofectamine 2000 (Invitrogen) or calcium phos-
phate, and the amount of DNA in each sample was equalized using vector
DNA. Transfected cells were harvested 48 hr posttransfection, using RIPA lysis
buffer (50 mM Tris-HCl [pH 7.4], 150 mMNaCl, 1% (v/v) NP40, 1% (w/v) deox-
ycholate 0.1% (w/v) SDS, and 1 mM EDTA) containing protease inhibitors and
phosphatase cocktail I and II (Sigma) (Li et al., 2007). In Figure 3D, cells were
treated with 20 mM roscovitine for 12 hr before harvest to minimize the contri-
bution of CDC2/CDK1. Immunoprecipitation and ChIP were carried out as
described previously (Zhu et al., 2009). For phosphatase treatment, the immu-
noprecipitated complex was resuspended in 13 NEBuffer and incubated with
10 units of calf intestinal phosphatase (New England Biolabs) at 37C for 1 hr.
The complex was then eluted with Laemmli sample buffer and subsequently
analyzed by SDS-PAGE and immunoblotting.
Histone Acetyltransferase Assay
TIP60 HAT activity was assayed using Flag-TIP60, Flag-TIP60S86/90A, and
HAT dead Flag-TIP60 immunoprecipitated from 293T cells cotransfected
with HA-BGLF4 or HA-BGLF4 kinase-dead mutant. Cells were treated with
20 mM roscovitine for 12 hr before harvest, and TIP60 HAT activity was as-
sayed using the HAT Assay Kit (Millipore) modified according to Sun et al.
(2005).October 20, 2011 ª2011 Elsevier Inc. 397
Figure 7. Model for Conserved Herpesvirus
Kinases in Regulating Viral Replication
through TIP60
The contribution of TIP60 activation by the
conserved herpesvirus kinases to lytic replication,
as illustrated mechanistically for EBV-infected
cells. TXN, transcription; P, phosphorylation; Ac,
acetylation; TF, transcription factor; Pol II, RNA
polymerase II; OriLyt, lytic replication origin.
Cell Host & Microbe
Herpesvirus Kinases Activate TIP60Virus Infection
For HCMV infection, HF cells were seeded into 24-well plates 1 day before
infection. The cells were washed with PBS, and HCMV-luciferase virus
(MOI = 1) was added to each well and incubated for 1.5 hr in 200 ml serum-
free Dulbecco’s modified Eagle’s medium (DMEM). Free viruses were
removed with washing, and cells were incubated in medium containing 4%
fetal bovine serum for 96 hr. To induce the EBV lytic cycle, Akata (EBV+) cells
were treated with 50 mg/ml of goat antihuman IgG (MP Biomedicals) for 24 hr,
and SNU719 (EBV+) cells were treated for 24 hr with 20 nM of bortezomib (Fu
et al., 2008).
Statistical Analysis
Statistical analyses employed a two-tailed Student’s t test. A p value of% 0.05
was considered statistically significant. The data are representative of at least
two independent experiments, and values are given as the mean of replicate
experiments ± SD.
SUPPLEMENTAL INFORMATION
Supplemental Information includes Supplemental Experimental Procedures,
six figures, and two tables and can be found with this article online at doi:10.
1016/j.chom.2011.08.013.
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